Nursing care
Mirtazapine: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Mirtazapine is a noradrenergic and specific serotonergic antidepressant given at bedtime for depression, often in older adults who are not eating or sleeping. It causes sedation and weight gain at low doses, which is the reason it gets chosen rather than an unwanted side effect. Check weight, appetite, and sedation level before each dose review.
Mechanism, simply
Mirtazapine blocks presynaptic alpha-2 adrenergic receptors, which increases release of noradrenaline and serotonin. It also blocks specific serotonin receptors (5-HT2 and 5-HT3), which is why it does not cause the sexual dysfunction or gastrointestinal upset seen with SSRIs.
The histamine H1 blockade is what produces the sedation and appetite stimulation. At lower doses (15 mg) the antihistamine effect dominates and sedation is stronger; at higher doses (30-45 mg) the noradrenergic effect increases and sedation can actually lessen. This dose-response pattern is worth knowing because it is counterintuitive and shows up on exams.
Indications you will see on the ward
Major depressive disorder is the primary indication, but the prescribing pattern tells you more than the diagnosis does. Mirtazapine is reached for specifically when depression comes with insomnia and poor appetite, which is common in older adults and in patients who are underweight or losing weight.
You will see it started in a frail elderly patient who has stopped eating, or in a patient coming off another antidepressant that caused insomnia or weight loss. It is sometimes used off-label for anxiety with sleep disturbance, though this is not its approved indication.
Assessment before administration
Take a baseline weight and ask about appetite and sleep pattern before the first dose, then track both at follow-up. A weight gain of several kilograms over weeks is expected and is not a reason to stop the drug on its own; it is the reason the drug was chosen.
Check baseline neutrophil count if the prescriber has ordered one, since mirtazapine carries a rare risk of agranulocytosis. Ask about any sore throat, fever, or mouth ulcers at each contact, and hold the dose and notify the prescriber if these appear.
Assess fall risk before the first few doses, particularly in older adults, because sedation peaks early in treatment and increases fall risk at night.
Toxicity and the antidote
Mirtazapine overdose is generally less dangerous than overdose with tricyclic antidepressants or SSRIs taken in combination with other serotonergic drugs. Expect sedation, disorientation, and tachycardia rather than the cardiac conduction problems seen with tricyclics.
There is no specific antidote. Management is supportive: airway protection if sedation is deep, cardiac monitoring, and activated charcoal if the patient presents early after ingestion and can protect their airway. Watch for serotonin syndrome if mirtazapine has been combined with another serotonergic agent, and treat that supportively as well since there is no reversal agent for it either.
Interactions that matter
Do not give with an MAOI or within 14 days of stopping one; the combination risks serotonin syndrome. Combining with other serotonergic drugs (SSRIs, SNRIs, tramadol, triptans) raises the same risk and should prompt closer monitoring for agitation, hyperthermia, and clonus.
Alcohol and other CNS depressants intensify the sedation, so ask about alcohol use and warn against driving until the sedative effect is known. CYP3A4 inhibitors such as ketoconazole or erythromycin can raise mirtazapine levels and increase sedation.
What the patient must be told
Tell the patient to take the dose at bedtime, not in the morning, because of the sedation. Warn them that weight gain and increased appetite are expected effects, not side effects to panic about, but that a large or rapid change should be discussed with the prescriber.
Explain that antidepressant effect takes two to four weeks to build, so they should keep taking it even if they do not feel different immediately. Tell them to report any fever, sore throat, or mouth sores straight away, and not to stop the drug suddenly without medical advice because of discontinuation symptoms.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our mental health practice questions are the closest set to what this page covers.
Common questions
Why does mirtazapine cause weight gain?
It blocks histamine H1 receptors, which stimulates appetite and produces sedation. This is why it is often chosen for depressed patients, especially older adults, who have stopped eating or sleeping well.
Is mirtazapine more sedating at low or high doses?
It is more sedating at lower doses, typically 15 mg, because the antihistamine effect dominates. At higher doses the noradrenergic effect increases and can partly offset the sedation, which surprises many students.
What lab value should you monitor with mirtazapine?
Watch for signs of agranulocytosis: fever, sore throat, or mouth ulcers. A neutrophil count may be checked if these symptoms appear, though routine monitoring is not standard for every patient.
Can mirtazapine be given with an SSRI?
It can be combined in some treatment-resistant depression regimens under specialist supervision, but the combination raises serotonin syndrome risk. Monitor for agitation, tremor, hyperthermia, and confusion if combined.
How long does mirtazapine take to work?
Sedation and appetite effects can appear within days, but the antidepressant effect typically takes two to four weeks. Tell the patient to continue the medication even before mood symptoms improve.
More on mental health